DOW JONES21,636.78-915.39 -4.06%
S&P 5002,541.47-88.60 -3.37%
NASDAQ7,502.38-295.16 -3.79%

HC Wainwright & Co. Maintains Buy on Voyager Therapeutics, Lowers Price Target to $18

HC Wainwright & Co. maintains Voyager Therapeutics (NASDAQ:VYGR) with a Buy and lowers the price target from $26 to $18.

Benzinga · 03/04/2020 16:19

HC Wainwright & Co. maintains Voyager Therapeutics (NASDAQ:VYGR) with a Buy and lowers the price target from $26 to $18.